Global Ophthalmology Market Research Report (2021 to 2027)

DublinAnd January 14, 2022 /PRNewswire/ – “Ophthalmology Market Research Report by Disease, by End User, by Region – Global Forecast to 2027 – COVID-19 Cumulative Impact Report” has been added to Show.

Research and Markets logo

Research and Markets logo

The global ophthalmology market size has been estimated 52.07 billion US dollars In 2020, it is expected to reach 55.28 billion US dollars In 2021, it is expected to grow at a compound annual growth rate of 6.52% 81.05 billion US dollars by 2027.

Market Statistics:

The report presents market size and forecast across five major currencies – US Dollar, Euro, British Pound, Japanese Yen and Australian Dollar. It helps organizations leaders make better decisions when currency exchange data is readily available. In this report, 2018 and 2019 are historical years, 2020 is a base year, 2021 is an estimated year, and the years 2022 to 2027 are the forecast period.

Competitive strategic window:

The Competitive Strategy Window analyzes the competitive landscape in terms of markets, applications, and geographies to help the seller determine the fit or suitability of its capabilities and opportunities for future growth prospects. Describes the optimal or favorable suitability for vendors to adopt successive merger and acquisition strategies, geographic expansion, research and development, and new product introduction strategies to carry out further expansion and growth of the business over a forecast period.

FPNV Matrix Positioning:

The FPNV Matrix positioning rates and ranks vendors in the Ophthalmology market based on business strategy (business growth, industry coverage, financial viability, channel support) and product satisfaction (value for money, ease of use, product features, customer support) that helps companies take Better decisions and an understanding of the competitive landscape.

Market share analysis:

Market share analysis provides an analysis of the vendors given their contribution to the market as a whole. It provides the idea of ​​revenue generation in the market as a whole as compared to other suppliers in the space. It provides insight into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing the market share provides an idea of ​​the size and competitiveness of the vendors for the base year. It reveals the characteristics of the market in terms of accumulation, fragmentation, domination, and consolidation.

Company Usability Profiles:

The report explores in depth recent significant developments by leading vendors and innovation profiles in the global ophthalmology market, including Alcon, Alkeus Pharmaceuticals, Bausch + Lomb, Carl Zeiss AG, ClearSight, CooperVision, Envisia Therapeutics, Essex Bio, EssilorLuxottica, Eyenovia and Gensight Biologics , Glaukos Corp., Hoya Corporation, Iris Pharma, Johnson & Johnson Vision, Kubota Pharmaceuticals, LC Technologies, NIDEK CO., LTD., Oraya Therapeutics, PanOptica, PharmOptima, Sensimed, ThromboGenics, Topcon, Topivert, Unimed Pharma, Vision Medicines, VisionCare and Wellstat Group.

The report provides insights into the following indicators:
1. Market Penetration: Provides comprehensive market information provided by the major players
2. Market Development: Provides in-depth information on profitable emerging markets and penetration analysis across mature market segments
3. Market diversification: Provides detailed information on new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of the leading players
5. Product development and innovation: Provides intelligent insights into future technologies, R&D activities and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the global Ophthalmology market?
2. What are the dampening factors and impact of COVID-19 on shaping the global Ophthalmology market during the forecast period?
3. What products/segments/applications/areas should be invested in during the forecast period of the global ophthalmology market?
4. What is the competitive strategic window of opportunity in the global Ophthalmology market?
5. What are the technology trends and regulatory frameworks in the global ophthalmology market?
6. What is the market share of the leading vendors in the global Ophthalmology market?
7. What are the approaches and strategic moves that are appropriate to enter the global ophthalmology market?

Main topics covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market insights
5.1 Market dynamics
5.1.1. drivers Increasing the number of elderly people in the world Availability of a solid healthcare infrastructure Rising eye care issues are attributed to changing lifestyles around the world
5.1.2. limitations High cost of treatment
5.1.3. chances Increased research and development to provide new treatment Production of new therapeutic drugs for the treatment of eye diseases is underway
5.1.4. Challenges Dear skilled professionals
5.2 Cumulative Impact of COVID-19

6. Ophthalmology market, by diseases
6.1 Introduction
6.2 Age-related macular degeneration
6.3 Cataracts
6.4 glaucoma
6.5. Inflammatory diseases
6.6. Aharon
6.7 Refractive disorders

7. Ophthalmology market, by end user
7.1 Introduction
7.2 Healthcare Providers
7.3. Hospitals
7.4. medical institutes
7.5 Research organizations

8. Americas eye disease market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Mexico
8.6 United States of America

9. Asia Pacific Ophthalmology Market
9.1 Introduction
9.2. Australia
9.3 China
9.4 India
9.5 Indonesia
9.6 Japan
9.7 Malaysia
9.8. philippines
9.9 Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. EuropeAnd Middle east & Africa Ophthalmology Market
10.1. an introduction
10.2. France
10.3. Germany
10.4. Italia
10.5. Holland
10.6. Qatar
10.7. Russia
10.8. Kingdom Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. The United Arab Emirates
10.12. United kingdom

11. Competitive landscape
11.1. FPNV Matrix Positioning
11.1.1. Quarters
11.1.2. business strategy
11.1.3. product satisfaction
11.2. Market Ranking Analysis
11.3. Market share analysis, by major player
11.4. Competitive Scenario
11.4.1. gain integration
11.4.2. Agreement, Cooperation and Partnership
11.4.3. New product launch and improvement
11.4.4. investment and financing
11.4.5. Award, recognition and expansion

12. Company Usability Profiles
12.1. Universe
12.2. Alkyus Pharmaceuticals
12.3. Bausch + Lomb
12.4. Carl Zeiss AG
12.6. Copper Vision
12.7. Envisia treatments
12.8 Essex Bio
12.9 Essilor Luxoteca
12.10. Ynovia
12.11. biology gensite
12.12. Glaucous Company
12.13. Hoya Company
12.14. Iris Pharma
12.15. Seeing Johnson and Johnson
12.16. Kubota Pharmaceuticals
12.17. LC . Technologies
12.18. NIDEK CO., LTD.
12.19. Uraya Healing
12.20. Pan Optica
12.21. Pharmoptimma
12.22. tangible
12.23. ThromboGenics
12.24. Topcon
12.25. Tobivert
12.26. Unimed Pharma
12.27. vision drugs
12.28. vision care
12.29. Wellstat Group

13. Appendix

For more information on this report, visit

Media contact:

Research and Markets
Laura Wood, director, mentor

For EST office hours, call +1-917-300-0470
For the US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1907
Fax (outside the US): +353-1-481-1716



View original content:—by-diseases-end-user-and-region-301461331. programming language

SOURCE Research & Markets

Leave a Comment